Sodium-glucose co-transporter-2 inhibitors and sacubitril/valsartan combination in patients with heart failure with reduced ejection fraction; does it deserve our attention?

被引：5
|
作者：
Patoulias, Dimitrios [1 ]
Papadopoulos, Christodoulos [2 ]
Doumas, Michael [1 ,3 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Propedeut Dept Internal Med 2, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Dept Cardiol 3, Thessaloniki, Greece
[3] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA
来源：
AMERICAN HEART JOURNAL | 2021年 / 236卷
关键词：
D O I：
10.1016/j.ahj.2021.02.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [31] Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction
    Tomasoni, Daniela
    Fonarow, Gregg C.
    Adamo, Marianna
    Anker, Stefan D.
    Butler, Javed
    Coats, Andrew J. S.
    Filippatos, Gerasimos
    Greene, Stephen J.
    McDonagh, Theresa A.
    Ponikowski, Piotr
    Rosano, Giuseppe
    Seferovic, Petar
    Vaduganathan, Muthiah
    Voors, Adriaan A.
    Metra, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 431 - 441
  • [32] Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction
    Falk, Jamie
    Potter, Jennifer
    Turgeon, Ricky D.
    CANADIAN FAMILY PHYSICIAN, 2021, 67 (09) : 678 - 678
  • [33] Could sweet pee be the answer? Applicability of use of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF)
    Sharma, A.
    Lakra, O.
    Al-Dulaimi, Z.
    Sethi, J.
    Shah, J.
    Hui, E.
    DIABETIC MEDICINE, 2021, 38
  • [34] Effects of Sodium-Glucose Co-Transporter-2 Inhibition on Pulmonary Arterial Stiffness and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction
    Camci, Sencer
    Yilmaz, Emre
    MEDICINA-LITHUANIA, 2022, 58 (08):
  • [35] In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
    Arshad, Muhammad Sameer
    Jamil, Adeena
    Greene, Stephen J.
    Van Spall, Harriette G. C.
    Fonarow, Gregg C.
    Butler, Javed
    Khan, Muhammad Shahzeb
    HEART FAILURE REVIEWS, 2025, 30 (01) : 89 - 101
  • [36] Initiation of sodium-glucose co-transporter-2 inhibitors in patients with heart failure in the acute medical setting
    Mihelcic, G.
    Furlan, T.
    Leskovar, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 250 - 250
  • [37] Role of sodium-glucose co-transporter-2 inhibitors in the management of heart failure in patients with diabetes mellitus
    Alkagiet, Stelina
    Tziomalos, Konstantinos
    WORLD JOURNAL OF DIABETES, 2020, 11 (05) : 150 - 154
  • [38] Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis
    Packer, Milton
    DIABETES OBESITY & METABOLISM, 2018, 20 (06): : 1361 - 1366
  • [39] Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
    Bo Liang
    Yi Liang
    Ning Gu
    BMC Cardiovascular Disorders, 22
  • [40] Sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism
    Anker, Stefan D.
    Khan, Muhammad Shahzeb
    Shahid, Izza
    Filippatos, Gerasimos
    Coats, Andrew J. S.
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (08) : 1250 - 1255
12345